202 related articles for article (PubMed ID: 20699639)
1. Reactivating the ARF-p53 axis in AML cells by targeting ULF.
Chen D; Yoon JB; Gu W
Cell Cycle; 2010 Aug; 9(15):2946-51. PubMed ID: 20699639
[TBL] [Abstract][Full Text] [Related]
2. Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor protein.
den Besten W; Kuo ML; Williams RT; Sherr CJ
Cell Cycle; 2005 Nov; 4(11):1593-8. PubMed ID: 16205118
[TBL] [Abstract][Full Text] [Related]
3. Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant.
Colombo E; Martinelli P; Zamponi R; Shing DC; Bonetti P; Luzi L; Volorio S; Bernard L; Pruneri G; Alcalay M; Pelicci PG
Cancer Res; 2006 Mar; 66(6):3044-50. PubMed ID: 16540653
[TBL] [Abstract][Full Text] [Related]
4. AKT regulates NPM dependent ARF localization and p53mut stability in tumors.
Hamilton G; Abraham AG; Morton J; Sampson O; Pefani DE; Khoronenkova S; Grawenda A; Papaspyropoulos A; Jamieson N; McKay C; Sansom O; Dianov GL; O'Neill E
Oncotarget; 2014 Aug; 5(15):6142-67. PubMed ID: 25071014
[TBL] [Abstract][Full Text] [Related]
5. Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses.
Chen D; Shan J; Zhu WG; Qin J; Gu W
Nature; 2010 Mar; 464(7288):624-7. PubMed ID: 20208519
[TBL] [Abstract][Full Text] [Related]
6. Nucleostemin stabilizes ARF by inhibiting the ubiquitin ligase ULF.
Lo D; Zhang Y; Dai MS; Sun XX; Zeng SX; Lu H
Oncogene; 2015 Mar; 34(13):1688-97. PubMed ID: 24769896
[TBL] [Abstract][Full Text] [Related]
7. Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function.
Korgaonkar C; Hagen J; Tompkins V; Frazier AA; Allamargot C; Quelle FW; Quelle DE
Mol Cell Biol; 2005 Feb; 25(4):1258-71. PubMed ID: 15684379
[TBL] [Abstract][Full Text] [Related]
8. Sumoylation induced by the Arf tumor suppressor: a p53-independent function.
Tago K; Chiocca S; Sherr CJ
Proc Natl Acad Sci U S A; 2005 May; 102(21):7689-94. PubMed ID: 15897463
[TBL] [Abstract][Full Text] [Related]
9. DNA damage, p14ARF, nucleophosmin (NPM/B23), and cancer.
Gjerset RA
J Mol Histol; 2006 Sep; 37(5-7):239-51. PubMed ID: 16855788
[TBL] [Abstract][Full Text] [Related]
10. Nucleophosmin and its AML-associated mutant regulate c-Myc turnover through Fbw7 gamma.
Bonetti P; Davoli T; Sironi C; Amati B; Pelicci PG; Colombo E
J Cell Biol; 2008 Jul; 182(1):19-26. PubMed ID: 18625840
[TBL] [Abstract][Full Text] [Related]
11. ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway.
Brady SN; Yu Y; Maggi LB; Weber JD
Mol Cell Biol; 2004 Nov; 24(21):9327-38. PubMed ID: 15485902
[TBL] [Abstract][Full Text] [Related]
12. Siva1 inhibits p53 function by acting as an ARF E3 ubiquitin ligase.
Wang X; Zha M; Zhao X; Jiang P; Du W; Tam AY; Mei Y; Wu M
Nat Commun; 2013; 4():1551. PubMed ID: 23462994
[TBL] [Abstract][Full Text] [Related]
13. Binding to nucleophosmin determines the localization of human and chicken ARF but not its impact on p53.
Moulin S; Llanos S; Kim SH; Peters G
Oncogene; 2008 Apr; 27(17):2382-9. PubMed ID: 17968318
[TBL] [Abstract][Full Text] [Related]
14. NMI mediates transcription-independent ARF regulation in response to cellular stresses.
Li Z; Hou J; Sun L; Wen T; Wang L; Zhao X; Xie Q; Zhang SQ
Mol Biol Cell; 2012 Dec; 23(23):4635-46. PubMed ID: 23034180
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitination of, and sumoylation by, the Arf tumor suppressor.
den Besten W; Kuo ML; Tago K; Williams RT; Sherr CJ
Isr Med Assoc J; 2006 Apr; 8(4):249-51. PubMed ID: 16671360
[TBL] [Abstract][Full Text] [Related]
16. GLTSCR2 promotes the nucleoplasmic translocation and subsequent degradation of nucleolar ARF.
Lee S; Cho YE; Kim SH; Kim YJ; Park JH
Oncotarget; 2017 Mar; 8(10):16293-16302. PubMed ID: 27323397
[TBL] [Abstract][Full Text] [Related]
17. Functional interplay between the DNA-damage-response kinase ATM and ARF tumour suppressor protein in human cancer.
Velimezi G; Liontos M; Vougas K; Roumeliotis T; Bartkova J; Sideridou M; Dereli-Oz A; Kocylowski M; Pateras IS; Evangelou K; Kotsinas A; Orsolic I; Bursac S; Cokaric-Brdovcak M; Zoumpourlis V; Kletsas D; Papafotiou G; Klinakis A; Volarevic S; Gu W; Bartek J; Halazonetis TD; Gorgoulis VG
Nat Cell Biol; 2013 Aug; 15(8):967-77. PubMed ID: 23851489
[TBL] [Abstract][Full Text] [Related]
18. ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor.
Chen D; Kon N; Li M; Zhang W; Qin J; Gu W
Cell; 2005 Jul; 121(7):1071-83. PubMed ID: 15989956
[TBL] [Abstract][Full Text] [Related]
19. Nucleophosmin is required for DNA integrity and p19Arf protein stability.
Colombo E; Bonetti P; Lazzerini Denchi E; Martinelli P; Zamponi R; Marine JC; Helin K; Falini B; Pelicci PG
Mol Cell Biol; 2005 Oct; 25(20):8874-86. PubMed ID: 16199867
[TBL] [Abstract][Full Text] [Related]
20. N-terminal polyubiquitination and degradation of the Arf tumor suppressor.
Kuo ML; den Besten W; Bertwistle D; Roussel MF; Sherr CJ
Genes Dev; 2004 Aug; 18(15):1862-74. PubMed ID: 15289458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]